title: Glyburide vs Insulin and Adverse Pregnancy Outcomes.
authors.affiliation: Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
authors.forename: Maisa N
authors.initials: MN
authors.lastname: Feghali
authors.affiliation: Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City.
authors.forename: Christina M
authors.initials: CM
authors.lastname: Scifres
authors.affiliation: Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
authors.forename: Steve N
authors.initials: SN
authors.lastname: Caritis
mesh_terms: D016640:Diabetes, Gestational / Q000188:drug therapy*; D005260:Female; D005905:Glyburide / Q000009:adverse effects*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D007328:Insulin / Q000009:adverse effects*; D011247:Pregnancy; D011256:Pregnancy Outcome
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D005905:Glyburide